HC Wainwright Cuts Price Target On This Stock By 50%? Also This Analyst Slashes PT On Cisco
September 22, 8:20 AM
Barclays cut the price target on Cisco Systems, Inc. (NASDAQ: CSCO) from $56 to $46. Barclays analyst Tim Long downgraded the stock from Overweight to Equal-Weight. Cisco shares rose 0.1% to $41.61 in pre-market trading.
Tilray’s Medical Cannabis Oral Solution Approved For Pharmaceutical Distribution In Italy
September 22, 7:23 AM
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), announced that FL Group S.R.L., a division of Tilray Medical in Italy, has received approval from the Italian Ministry of Health to import and distribute Tilray’s
US Stocks Could Remain Jittery Thursday Over Fed Rate Hike As S&P 500, Nasdaq Futures See Volatility — McDonald’s In Focus
September 22, 7:23 AM
The major U.S. index futures are flatlining, as traders are digesting the implication of the Fed's policy statement and a couple of interest rate decisions from Japan and the United Kingdom.
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
September 22, 7:22 AM
Nanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime for inoperable locoregional recurrent or recurrent and metastatic head and neck squamous cell carcinoma that is resistant to prior immunotherapy.
Ayr Wellness’ Cannabis Brand Lost In Translation Debuts In Four Additional States
September 22, 6:56 AM
Vertically integrated cannabis company Ayr Wellness Inc. (CSE: AYR.A) (OTCQX: AYRWF) announced the launch of its Lost in Translation cannabis brand across four additional states in the company's operational footprint - Arizona, Florida, New Jersey and Pennsylvania.
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
September 22, 6:34 AM
Gainers
Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
Chemours, Alcoa And Other Big Losers From Wednesday
September 22, 5:59 AM
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.
GSK and Spero Therapeutics Announced Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr; Spero to Receive $66M Upfront Plus Potential Milestones Up to $375M
September 22, 4:53 AM
GSK (LSE/NYSE: GSK) and Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced they have entered into an exclusive license agreement for Spero's late-stage antibiotic asset, tebipenem HBr.
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
September 22, 4:04 AM
Gainers